Spruce Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
Spruce Biosciences has a total shareholder equity of $51.6M and total debt of $2.1M, which brings its debt-to-equity ratio to 4.2%. Its total assets and total liabilities are $65.1M and $13.5M respectively.
Key information
4.2%
Debt to equity ratio
US$2.15m
Debt
| Interest coverage ratio | n/a |
| Cash | US$60.06m |
| Equity | US$51.64m |
| Total liabilities | US$13.46m |
| Total assets | US$65.10m |
Financial Position Analysis
Short Term Liabilities: SPRB's short term assets ($63.6M) exceed its short term liabilities ($11.9M).
Long Term Liabilities: SPRB's short term assets ($63.6M) exceed its long term liabilities ($1.6M).
Debt to Equity History and Analysis
Debt Level: SPRB has more cash than its total debt.
Reducing Debt: SPRB had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SPRB has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: SPRB has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 18.8% each year.